VitaSpring Biomedical Co. Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-3.4K | $5.2K |
| FY2019 | — | $-6.9K | $105 |
| FY2020 | — | — | $0 |
| FY2021 | — | $96.4K | $45.4K |
| FY2022 | — | $1.6M | $107.2K |
| FY2023 | — | $-2.4M | $29.7K |
| FY2024 | — | $-3.4M | $0 |
| FY2025 | — | $-4.0M | $0 |
| FY2026 | — | $-4.4M | $2.1K |